Nuclera joins Tech Nation’s Future Fifty program

Nuclera recognized as one of UK’s most exciting growth stage companies.

Novo Nordisk CEO skeptical of PBM promises in Senate hearing on weight loss drug prices

Sen. Bernie Sanders (I-VT) told Novo Nordisk CEO Lars Fruergaard Jørgensen that three major pharmacy benefit managers have agreed not to penalize the company for

September 25, 2024

Increased daily step count may reduce the risk of death and cardiovascular disease

Every additional step up to around 10,000 steps per day reduces the risk of death and cardiovascular disease (CVD), regardless of how much remaining time

March 6, 2024

Dutch Committee Seeks to Expedite MDMA-Assisted Therapy for PTSD – Psychedelic Alpha

Independent data-driven reporting, analysis and commentary on the psychedelics space: from business and drug development through to policy reform and culture. Subscribe AnnuallySubscribe Monthly Already

July 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.